{"id":"W1831196039","doi":"10.1007/s10549-015-3612-z","title":"Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; Susan G. Komen for the Cure; Pfizer; Ipsen Fund; Canadian Cancer Society Research Institute; Ipsen; National Institute for Health and Care Research; Cancer Research UK; National Health and Medical Research Council; Breast Cancer Research Foundation; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Oncosuisse","keywords":"Exemestane; Breast cancer; Medicine; Tamoxifen; Internal medicine; Progesterone receptor; Oncology; Estrogen receptor; Population; Cancer; Hormone receptor; Gynecology; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008633411,0.0004051267,0.0008318414,0.00008121118,0.0002137035,0.00007024229,0.00009596341,0.00011257,0.00001243306],"category_scores_gemma":[0.00008800057,0.0002750633,0.00004837228,0.0001687143,0.0006876542,0.00003045326,0.0001609381,0.0001275555,2.867033e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002650027,"about_ca_system_score_gemma":0.0007263441,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009496143,"about_ca_topic_score_gemma":0.001358933,"domain_scores_codex":[0.997041,0.0004988963,0.0004237696,0.0009504154,0.0003827737,0.0007031085],"domain_scores_gemma":[0.9978099,0.0003461174,0.0001690758,0.0002502392,0.0007706878,0.0006539266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1437797,0.001926278,0.5547431,0.00007948885,0.005651182,0.00001334271,0.001835316,0.000006191773,0.008606164,0.00002750741,0.0008152746,0.2825165],"study_design_scores_gemma":[0.01791213,0.01678553,0.9561191,0.00011329,0.0001648287,0.00006149727,0.000549991,0.00002110393,0.007379661,0.00009140944,0.0005344612,0.0002669818],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814765,0.008250099,0.00006454023,0.001714804,0.00004249448,0.002555627,0.005846394,0.00001381681,0.00003572701],"genre_scores_gemma":[0.977132,0.02001248,0.0004152399,0.00004521703,0.0002467938,0.001972297,0.00006039636,0.00003977579,0.00007579852],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4013761,"threshold_uncertainty_score":0.9999701,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06265246098170117,"score_gpt":0.3926188715416153,"score_spread":0.3299664105599141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}